updates in the treatment of r/r lbcl: promising novel agents in the pipeline
Published 1 year ago • 55 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
3:58
extended follow-up of glofitamab monotherapy in r/r lbcl: durability of cr and likelihood of crs
-
1:46:07
hematology lecture
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:41
israeli company on the edge of finding diabetes cure
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
1:25
the current approach to managing patients with prefibrotic pmf
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
2:25
key ebmt guideline updates for the treatment and prophylaxis of gvhd
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:31
novel treatment agents and how they're changing the mpn field
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
0:58
dara-rvd in the treatment of hr-smm: an ongoing phase ii trial
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
1:30
results of the ruxopeg trial: combining ruxolitinib and interferon in patients with myelofibrosis
-
2:41
an overview of the latest advances in hematology